Lonardo, Amedeo

Sex and gender: modifiers of health, disease, and medicine

Mauvais-Jarvis, F., Bairey Merz, N., Barnes, P. J., Brinton, R. D., Carrero, J.-J., DeMeo, D. L., De Vries, G. J., Epperson, C. N., Govindan, R., Klein, S. L., et al. (2020) · The Lancet

Sex and Gender in HealthcareDiversity and Career in Medicine

Cited by 2,001

Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis

Mantovani, A., Petracca, G., Beatrice, G., Csermely, A., Lonardo, A., Schattenberg, J. M., Tilg, H., Byrne, C. D., & Targher, G. (2022) · Gut

Liver Disease Diagnosis and TreatmentChronic Kidney Disease and Diabetes

Cited by 402

Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus

Targher, G., Lonardo, A., & Byrne, C. D. (2018) · Nature Reviews Endocrinology

Liver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 397

Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials

Mantovani, A., Petracca, G., Beatrice, G., Csermely, A., Lonardo, A., & Targher, G. (2021) · Metabolites

Liver Disease Diagnosis and TreatmentDiabetes Treatment and Management

Cited by 299

Epidemiology and pathophysiology of the association between NAFLD and metabolically healthy or metabolically unhealthy obesity

Lonardo, A., Mantovani, A., Lugari, S., & Targher, G. (2020) · Annals of Hepatology

Liver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 150

Sexual Dimorphism of NAFLD in Adults. Focus on Clinical Aspects and Implications for Practice and Translational Research

Lonardo, A., & Suzuki, A. (2020) · Journal of Clinical Medicine

Liver Disease Diagnosis and TreatmentAlcohol Consumption and Health Effects

Cited by 129